VMNT Vemanti Group Inc (QB)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Tran Tan	2. Issuer Name and Ticker or Trading Symbol Vemanti Group, Inc. [ VMNT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    __X__ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) President, CEO, CFO
(Last)          (First)          (Middle) 7545 IRVINE CENTER DR., STE. 200	3. Date of Earliest Transaction (MM/DD/YYYY) 7/21/2021
(Street) IRVINE, CA 92618 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	7/21/2021		S		500	D	$0.759	27293426	D
Common Stock	7/21/2021		S		1000	D	$0.761	27292426	D
Common Stock	7/21/2021		S		694	D	$0.80	27291732	D
Common Stock	7/21/2021		S		4000	D	$0.74	27287732	D
Common Stock	7/21/2021		S		4000	D	$0.72	27283732	D
Common Stock	7/21/2021		S		2500	D	$0.74	27281232	D
Common Stock	7/21/2021		S		2000	D	$0.765	27279232	D
Common Stock	7/21/2021		S		2500	D	$0.80	27276732	D
Common Stock	7/21/2021		S		2500	D	$0.79	27274232	D
Common Stock	7/21/2021		S		2500	D	$0.782	27271732	D
Common Stock	7/21/2021		S		2500	D	$0.775	27269232	D
Common Stock	7/21/2021		S		2500	D	$0.77	27266732	D
Common Stock	7/22/2021		S		2500	D	$0.77	27264232	D
Common Stock	7/22/2021		S		2500	D	$0.779	27261732	D
Common Stock	7/22/2021		S		2500	D	$0.769	27259232	D
Common Stock	7/22/2021		S		2500	D	$0.739	27256732	D
Common Stock	7/22/2021		S		2000	D	$0.759	27254732	D
Common Stock	7/22/2021		S		2500	D	$0.755	27252232	D
Common Stock	7/23/2021		S		2500	D	$0.759	27249732	D
Common Stock	7/23/2021		S		2500	D	$0.749	27247232	D
Common Stock	7/23/2021		S		2500	D	$0.729	27244732	D
Common Stock	7/23/2021		S		6500	D	$0.703	27238232	D
Common Stock	7/23/2021		S		2500	D	$0.719	27235732	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Tran Tan 7545 IRVINE CENTER DR. STE. 200 IRVINE, CA 92618	X	X	President, CEO, CFO

Signatures
/s/ Tan Tran		7/23/2021
**Signature of Reporting Person		Date